RxDoctor Payments Data

John Walker, MD

Family Medicine · Hammond, LANPI 1477536324

Payments from drug & device makers

$7,131in general payments, 2019–2025

Across 445 payments — averaging $16.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$1K
  • Amgen$788
  • Novo Nordisk$770
  • Takeda Pharmaceuticals U.S.A., Inc.$564
  • Lilly USA, LLC$551
  • AstraZeneca$487
  • plus $3K from 35 others

What the payments were for

  • Food & beverage$7,125100%
  • Education$60%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$7,131 in reported general payments places this provider in the 85th percentile of 1,469 family medicine providers in Louisiana.

See all family medicine providers in Louisiana

Medicare billing

Part B allowed, 2024
$40,647
Medicare patients
159
Services billed
424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide146$162,077
MounjaroTirzepatide97$132,302
JardianceEmpagliflozin62$59,410
TrulicityDulaglutide36$38,889
Trelegy ElliptaFluticasone/Umeclidin/Vilanter42$31,932
FarxigaDapagliflozin Propanediol30$23,000
LinzessLinaclotide22$15,200
XareltoRivaroxaban30$13,753
PremarinEstrogens, Conjugated14$7,510
JanumetSitagliptin Phos/Metformin Hcl11$6,317
Lantus SolostarInsulin Glargine,hum.Rec.Anlog31$4,125
Atorvastatin Calcium314$3,607
SynthroidLevothyroxine Sodium44$3,542
Levothyroxine Sodium271$2,987
Pantoprazole Sodium149$2,321

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro, Trulicity$551$171,191133 claims
Novo NordiskOzempic$770$162,077146 claims
Boehringer IngelheimJardiance$128$59,41062 claims
GSKTrelegy Ellipta$1,056$31,93242 claims
AstraZenecaFarxiga$487$23,00030 claims
AbbVieLinzess, Synthroid$402$18,74266 claims
Johnson & JohnsonXarelto$200$13,75330 claims
PfizerPremarin$175$7,51014 claims
MerckJanumet$152$6,31711 claims
Hikma Pharmaceuticals USAPhenobarbital$22$80713 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,469 family medicine providers in Louisiana.

Other family medicine in Hammond

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →